Are chondrocytes damaged when rheumatologic inflammation is suppressed? - Wikidata - awgldk - TriplyDB

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

http://www.wikidata.org/entity/Q51370938

about

Assessing the negative impact of phenyl alkanoic acid derivative, a frequently prescribed drug for the suppression of pain and inflammation, on the differentiation and proliferation of chondrocytes Can a Biodegradable Implanted Bilayered Drug Delivery System Loaded with BMP-2/BMP-12 Take an Effective Role in the Biological Repair Process of Bone-Tendon Injuries? A Preliminary Report.Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes.Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough?

P2860

Q36065254-FE37989A-B886-4C41-8227-5C42D4AA3F5E Q38703487-6612FE70-59B5-46D7-A3B9-7DD72007BB0E Q38708437-9FFF682C-31B4-4543-BFE2-3463ED9680E5 Q42204107-195B5EDD-A1FF-497C-BA21-AB6F31BF4238

P2860

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

http://www.wikidata.org/entity/Q51370938

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@en

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@nl

type

label

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@en

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@nl

prefLabel

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@en

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@nl

P1433

Q51370938-190D627D-812E-4F7B-8B72-910F333CB016

P1476

Q51370938-21A2B93A-8A64-466F-8673-3C38646E8EA0

P2093

Q51370938-059F3052-9D68-483F-8225-B128F3BB1E25

Q51370938-21C018B4-2BD5-4032-8C25-BBE1E4F38845

Q51370938-2F8C51BF-91F1-45F9-9E65-B108E0C4DC25

Q51370938-5D41B192-F206-4B5B-A718-6E8C1ECDC0E7

Q51370938-7162310C-0158-4A1B-9DA1-13082254D822

Q51370938-E96450D8-066A-4AF0-BFF5-2EF5D64D072F

P2860

Q51370938-1F9AE823-96A6-44F6-91D5-68DB244DAB6B

Q51370938-20D71762-85C9-457F-9722-DE345768F902

Q51370938-274C195D-D2ED-4F93-B5EB-AFED28A4DC01

Q51370938-39D628F6-9206-479B-A1A2-4EF7DFF24A91

Q51370938-3A33BA46-AA77-4F8F-8FDD-41F934D3EB15

Q51370938-402F29B6-1B55-4680-A29D-76A8CC23AE30

Q51370938-56DCE267-190C-47BE-8255-2BBB7DACEAFC

Q51370938-77BCB07D-3E84-4080-9D08-26B217ABDBA9

Q51370938-884A8397-02AF-4C07-9C6A-B2B4B669473E

Q51370938-93789046-8765-4425-BC10-9D4C41F9343F

P304

Q51370938-4A16C5A1-D920-4AE3-9DD9-07F07D27EF88

P31

Q51370938-32A9B231-00C1-40B4-86D0-5216DA0D9695

P356

Q51370938-FEEE1A6D-26CB-42EB-A6D3-C3505AECCAD0

P433

Q51370938-A051F06D-A8F5-4E30-9FC0-9D4107C87AC8

P478

Q51370938-FA549F93-CC5C-4424-8D3B-57E45E5EB92D

P577

Q51370938-FFB35A83-90D8-435F-8886-EDDCD401E2B6

P698

Q51370938-01B666CF-9827-4D57-838C-B92CA9779DBE

P921

Q51370938-797F5D6C-AC99-4831-992F-C081CCC11AF1

P356

01480545.2016.1166249

P1433

Drug and Chemical Toxicology

P1476

Are chondrocytes damaged when rheumatologic inflammation is suppressed?

@en

P2093

Aliye Yildirim Guzelant

http://www.w3.org/2001/XMLSchema#string

Duygu Yasar Sirin

http://www.w3.org/2001/XMLSchema#string

Mahir Mahirogullari

http://www.w3.org/2001/XMLSchema#string

Mehmet Isyar

http://www.w3.org/2001/XMLSchema#string

Selami Cakmak

http://www.w3.org/2001/XMLSchema#string

İbrahim Yilmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.

Pregnancy outcomes after maternal exposure to rituximab.

Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.

Synergistic Effect of TGF-β1 And BMP-7 on Chondrogenesis and Extracellular Matrix Synthesis: An In Vitro Study.

Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.

Does insulin, transferrin and selenous acid preparation effect chondrocyte proliferation?

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Biological therapies directed against cells in autoimmune disease.

Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review.

P304

13-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01480545.2016.1166249

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27079996

http://www.w3.org/2001/XMLSchema#string

P921